<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>767</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>12023403</PubmedId>
            <Abstract>Dengue hemorrhagic fever (DHF), the severe manifestation of dengue virus (DV) infection characterized by plasma leakage, is more common in secondary DV infections in previously infected individuals and is associated with high levels of immune activation. To determine the Ag specificity of this immune response, we studied the response to an HLA-B*07-restricted T cell epitope, residues 221-232 of the DV NS3 protein, in 10 HLA-B*07(+) Thai children who were studied during and after acute DV infections. Peptide-specific T cells were detected in 9 of 10 subjects. The frequency of peptide-specific T cells was higher in subjects who had experienced DHF than in those who had experienced DF. We also detected peptide-specific T cells in PBMC obtained at the time of the acute DV infection in 2 of 5 subjects. These data suggest that the NS3 (221-232) epitope is an important target of CD8(+) T cells in secondary DV infection and that the activation and expansion of DV-specific T cells is greater in subjects with DHF than in those with dengue fever. These findings support the hypothesis that activation of DV-specific CD8(+) T cells plays an important role in the pathogenesis of DHF.</Abstract>
            <ArticleYear>2002</ArticleYear>
            <ArticlePages>5959-65</ArticlePages>
            <ArticleTitle>T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severity.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Zivna</LastName>
                    <ForeName>Iva</ForeName>
                </Author>
                <Author>
                    <LastName>Green</LastName>
                    <ForeName>Sharone</ForeName>
                </Author>
                <Author>
                    <LastName>Vaughn</LastName>
                    <ForeName>David W</ForeName>
                </Author>
                <Author>
                    <LastName>Kalayanarooj</LastName>
                    <ForeName>Siripen</ForeName>
                </Author>
                <Author>
                    <LastName>Stephens</LastName>
                    <ForeName>Henry A F</ForeName>
                </Author>
                <Author>
                    <LastName>Chandanayingyong</LastName>
                    <ForeName>Dasnayanee</ForeName>
                </Author>
                <Author>
                    <LastName>Nisalak</LastName>
                    <ForeName>Ananda</ForeName>
                </Author>
                <Author>
                    <LastName>Ennis</LastName>
                    <ForeName>Francis A</ForeName>
                </Author>
                <Author>
                    <LastName>Rothman</LastName>
                    <ForeName>Alan L</ForeName>
                </Author>
            </Authors>
            <Affiliations>Center for Infectious Disease and Vaccine Research, University of Massachusetts Medical School, Worcester, MA 01655, USA.</Affiliations>
            <ArticleChemicalList>Epitopes, T-Lymphocyte;HLA-B Antigens;HLA-B*07 antigen;HLA-B7 Antigen;Interleukin-2;NS3 protein, flavivirus;Peptide Fragments;RNA, Viral;Viral Nonstructural Proteins;Serine Endopeptidases;RNA Helicases</ArticleChemicalList>
            <ArticleMeshHeadingsList>Adolescent; Child; Child, Preschool; Dengue(immunology); Epitopes, T-Lymphocyte; HLA-B Antigens(immunology); HLA-B7 Antigen; Humans; Infant; Interleukin-2(pharmacology); Peptide Fragments(immunology); Prospective Studies; RNA Helicases; RNA, Viral(blood); Serine Endopeptidases; T-Lymphocytes(immunology); Viral Nonstructural Proteins(immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>168</Volume>
                <Issue>11</Issue>
                <Title>Journal of immunology (Baltimore, Md. : 1950)</Title>
                <Issn>0022-1767</Issn>
                <MedlineTa>J Immunol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>DV-NS3 221-232</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LAPTRVVAAEME</LinearSequence>
                        <StartingPosition>221</StartingPosition>
                        <EndingPosition>232</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA40704.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11070</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Pg 5961</LocationOfData>
                <EpitopeId>34918</EpitopeId>
                <ReferenceStartingPosition>221</ReferenceStartingPosition>
                <ReferenceEndingPosition>232</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The epitope sequence is identical in Dengue virus type 2 and type 3. In type 1, there are two differences - S at position 9 and A at position 12.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Tables II and III</LocationOfData>
                        <TCellId>8020</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:12206</DiseaseState>
                                <DiseaseStage>Post</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11070</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Dengue Virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11070</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Dengue virus (DV) specific CTL clones were isolated by limiting dilution. PBMC from subject who had acute infection were stimulated with DV in bulk culture and restimulated every 2 week to obtain the CTL clones.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <AutologousOrSyngeneic>N</AutologousOrSyngeneic>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>300</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>DV-NS3 221-232</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LAPTRVVAAEME</LinearSequence>
                                        <StartingPosition>221</StartingPosition>
                                        <EndingPosition>232</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA40704.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11070</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope was identified by trunction analysis using BLCL target cells infected with recombinant vaccinia virus expressing truncations of NS3 protein and also with BLCL pulsed with the peptide. MHC restriction was confirmed by the use of various target cells expressing different alleles.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table VII</LocationOfData>
                        <TCellId>8024</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:12205</DiseaseState>
                                <DiseaseStage>Post</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11070</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Dengue Virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11070</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Two dengue virus (DV) specific CTL clones were isolated by limiting dilution. PBMC from subject who had acute infection were stimulated with DV in bulk culture and restimulated every 2 week to obtain the CTL clones.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <AutologousOrSyngeneic>N</AutologousOrSyngeneic>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>300</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>DV-NS3 221-232</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LAPTRVVAAEME</LinearSequence>
                                        <StartingPosition>221</StartingPosition>
                                        <EndingPosition>232</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA40704.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11070</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>6</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>CTL Lines isolated from one subject was tested for its ability to lyse peptide pulsed target cells from six other subjects. MHC restriction was confirmed by the use of various targets cells expressing different alleles (Table II).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table IV</LocationOfData>
                        <TCellId>8022</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:12205</DiseaseState>
                                <DiseaseStage>Post</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11070</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Dengue Virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Out of 10 subjects identified for this study, 5 had Dengue Fever and other 5 had Dengue Hemorrrhagic Fever.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>300</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>DV-NS3 221-232</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LAPTRVVAAEME</LinearSequence>
                                        <StartingPosition>221</StartingPosition>
                                        <EndingPosition>232</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA40704.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11070</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>10</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>9</NumberOfSubjectsResponded>
                            <ResponseFrequency>90</ResponseFrequency>
                            <AssayComments>5 of the 10 subjects were tested during two stages : during the acute/early stage of infection and during the late convalescent stage (6mo after infection). T cells were dectected in 2 out of 5 subjects during the actue phase. MHC restriction of the epitope was confirmed by various targets cells expressing different alleles (Table II). The frequency of peptide-specific T cells in late convalescent PBMC was higher in subjects who had Dengue Hemorrhagic Fever than those with Dengue Fever (Figure 1).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>DV-NS3 527-535</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GESRKTFVE</LinearSequence>
                        <StartingPosition>2001</StartingPosition>
                        <EndingPosition>2009</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P27915.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11069</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Pg 5961</LocationOfData>
                <EpitopeId>19434</EpitopeId>
                <ReferenceStartingPosition>527</ReferenceStartingPosition>
                <ReferenceEndingPosition>535</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope sequence is less conserved in Dengue virus types. Position 3 is Alanine in DV types 1 and 2, Serine in type 3 and Glutamine in type 4; Position 9 is Glutamic acid in types 1,3 and 4 but aspartic acid in type 2.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Table V</LocationOfData>
                        <TCellId>8025</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:12206</DiseaseState>
                                <DiseaseStage>Post</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11069</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Dengue Virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11069</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Dengue virus (DV) specific CTL clones were isolated by limiting dilution. PBMC from subject who had acute infection were stimulated with DV in bulk culture and restimulated every 2 week to obtain the CTL clones.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <AutologousOrSyngeneic>N</AutologousOrSyngeneic>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>300</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>DV-NS3 527-535</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GESRKTFVE</LinearSequence>
                                        <StartingPosition>2001</StartingPosition>
                                        <EndingPosition>2009</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P27915.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11069</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope was identified by trunction analysis using BLCL target cells infected with recombinant vaccinia virus expressing truncations of NS3 protein and also with BLCL pulsed with the peptide. MHC restriction was confirmed by the use of various target cells expressing different alleles.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

